Welcome to the UPF Digital Repository
Browsing by Author "Du, Juan"
- Home
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Du, Juan"
Now showing items 1-4 of 4
-
Sisteré-Oró, Marta; Andrade, Naína; Wortmann, Diana D.J.; Du, Juan; Garcia Giralt, Natàlia; González-Cao, María; Güerri Fernández, Roberto; Meyerhans, Andreas (Frontiers, 2022)Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific ...
-
Garcia Giralt, Natàlia; Du, Juan; Marin Corral, Judith; Bódalo-Torruella, Marta; Blasco-Hernando, Fabiola; Muñoz-Bermúdez, Rosana; Clarós, Miquel; Nonell Mazelón, Lara; Perera Bel, Júlia; Fernández-González, Marta; Nogués Solan, Francesc Xavier; Sorli Redó, M. Luisa; Güerri Fernández, Roberto (Nature Research, 2022)One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS). Several physiological parameters are altered ...
-
Sendra, Elena; López Montesinos, Inmaculada; Rodríguez-Alarcón, Alicia; Du, Juan; Siverio-Parès, Ana; Arenas-Miras, María Del Mar; Cañas-Ruano, Esperanza; Prim, Núria; Duran Jordà, Xavier, 1974-; Blasco-Hernando, Fabiola; García-Alzórriz, Enric; Cots Reguant, Francesc; Ferrández, Olivia; Gómez-Zorrilla, Silvia (MDPI, 2022)The objective was to compare clinical characteristics, outcomes, and economic differences in complicated urinary tract infections (cUTI) caused by extensively drug-resistant Pseudomonas aeruginosa (XDR P. aeruginosa) and ...
-
Pascual-Dapena, Ana; Chillarón Jordan, Juan José; Llauradó Cabot, Gemma; Arnau-Barrés, Isabel; Flores-Le-Roux, Juana Antonia; López Montesinos, Inmaculada; Sorli Redó, M. Luisa; Martínez-Pérez, Juan Luis; Gómez-Zorrilla, Silvia; Du, Juan; García-Giralt, Natalia; Güerri Fernández, Roberto (Frontiers, 2022)Background: CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio ...
Now showing items 1-4 of 4
© Universitat Pompeu Fabra | Plaça de la Mercè, 10-12. 08002 Barcelona | T. (+34) 93 542 20 00